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Understanding Neonatal Non invasive ventilation: Part 1 
Julia Petty 
Introduction 
Many of the babies admitted to the neonatal unit require some degree of respiratory support 
at varying levels for a given time period as dictated by individualised assessment of their overall 
condition. This Fact Sheet, following on from Oxygen therapy by Fallon (2012), offers an 
overview of current non-invasive ventilation practice in neonatal care focusing on the terms 
and modes used. The aim is for the reader to understand the range of strategies used to 
support the neonate’s respiratory system in line with the relevant evidence for delivery of best 
practice for the neonate and family.  
 
Respiratory management in the context of neonatal care 
Neonates require ventilator support to augment their own respiratory system when this is 
unable to provide adequate support and gaseous exchange during respiratory compromise or 
failure. The aim of any neonatal respiratory support strategy is to achieve adequate gaseous 
exchange without lung injury: in other words, the goal must be a healthy neonate and child 
with no resultant chronic lung disease (Bellettato et al, 2011), one of the potential and 
significant long-term effects of prolonged mechanical ventilation in the neonatal period. 
Ventilation support can be viewed within the framework of dependency levels as described by 
BAPM (2010) and the DoH (2009): 
1- Special care: A neonate in special care may not require any respiratory support and may 
simply be observed if there is a suspected or actual concern at birth or they may receive 
a low percentage and / or flow of oxygen due to mild or recovering respiratory 
compromise or disease. 
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2- High Dependency: A neonate in high dependency requires a greater level of support and 
may receive modes such as continuous positive airway pressure (CPAP), Biphasic 
pressure and / or high flow oxygen therapy, again as dictated by their condition. 
3- Intensive care; A neonate in intensive care in many cases will require full ventilation for 
a given time period either by conventional or non-conventional means. 
 
A neonate can be admitted to any of these three levels or they may experience all of them 
during their neonatal unit stay.  As an example, the sickest neonate is generally admitted to 
intensive care for full ventilator support. The subsequent journey through the neonatal unit 
then involves them progressing to high dependency when their condition allows and when they 
are able to be extubated to CPAP or Biphasic pressure. Thereafter the aim is for them to 
progress to special care where they may still require oxygen therapy. As their need for support 
for their respiratory and other systems lessens and their condition improves, they will then be 
able to wean off oxygen to be discharged home at an appropriate time.  
 
Overview of non-invasive respiratory support strategies in the neonatal unit 
Explanations of the strategies will now be given according to the above dependency levels from 
1 through to 3.   
OXYGEN THERAPY: Supplementary oxygen in self ventilating neonates can be delivered by 
various means depending on the oxygen requirement. If requirements are relatively low, then 
ambient oxygen can be given into an incubator or via a head box with the use of an oxygen 
analyzer to measure the percentage administered. For longer term delivery, low flow (less than 
1 litre / minute) nasal cannula oxygen is given and weaned down slowly until the neonate is 
able to ventilate in room air. In addition, high flow (1-8 litres/ minute) nasal cannula oxygen 
therapy has recently been introduced in the form of the Vapotherm © device (Image 1). This is 
a thermally controlled humidification system (at 95% or greater relative humidity) that flushes 
nasopharyngeal dead space.  It is documented that this therapy can be suitable as an 
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alternative to continuous positive airway pressure (CPAP), for neonates with nasal injury or for 
those who are very unsettled from prolonged CPAP (Lawn, 2007).  Research in this therapy 
within the adult field is overall positive and as Lawn reports, the benefits from one unit’s 
experience in neonates is clear. Although work is emerging on this therapy in neonates, further 
research is required to substantiate benefits (Hochwald and Osiovich; 2010; Wilkinson et al, 
2008; Wilkinson et al, 2011). 
High flow oxygen via this method is one of the ‘non-invasive’ strategies available, a vitally 
important concept in neonatal ventilation practice given the potential damaging effects of full 
respiratory support by endotracheal intubation and long term ventilation. This will be 
addressed in more detail in a later Fact sheet.   Most commonly used in clinical practice in 
relation to non-invasive intervention is continuous positive airway pressure (CPAP).   
 
Image 1: High Flow oxygen Vapotherm device © Source:  
CPAP: A constant positive pressure is applied to the airway of a spontaneously breathing 
neonate to maintain adequate functional residual capacity within the alveoli and prevent 
atelectasis.   In current practice, binasal CPAP has superseded the single nasal prong and is 
administered non-invasively by a Flow driver via two short prongs (see images 2 and 3) or nasal 
mask. DePaoli et al (2008) report on this method being preferable to single prong use when 
delivered by a flow driver. The device used to deliver the gases to the neonate’s nose is 
designed to support the baby’s breathing throughout the respiratory cycle in that there is a 
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special ‘flip’ mechanism. This is best explained in the following Table taken and adapted from 




Table 1: Explanation of the ‘flip’ mechanism in the Flow driver 
 
 
Inspiratory flow; The flow provided by the Infant Flow SiPAP system is accelerated in the twin injector 
nozzles of the Infant Flow generator. When the baby makes a spontaneous inspiratory effort, the Flow 
generator converts the kinetic energy of the flow to pressure, thereby reducing the work of breathing 
and maximizing pressure stability at the baby interface. 
Expiratory flow; When the baby exhales, the forward velocity of the airflow decreases. This allows the 
gas flow to “flip” from the nasal prongs to the expiratory tube and this continuous gas flow provides 
residual gas pressure enabling stable CPAP pressure delivery throughout the respiratory cycle. When 
expiratory effort stops, the flow instantly flips back to the inspiratory position. 
 
 
 Davis and Henderson Smart (2003) also report how binasal CPAP prevents failure of 
extubation. Given the relationship between flow and pressure, generally, a flow of 8-10 litres / 
minute should give a pressure of 4-6 cm / water (see image 2) provided that there is an 
adequate seal at the nostrils. Altering the flow will affect the pressure given. For some 
neonates, it is necessary to increase the flow to give a higher pressure of 6-7 cm / water 
(subject to individual assessment by ward medical / nursing team). Once the baby’s lungs 
improve, the flow and subsequent pressure can then be reduced according to the baby’s 
condition and or the neonate can ‘cycle’ on and off for agreed periods of time until able to 
tolerate ventilating without pressure.  Jardine et al (2011) found that weaning from CPAP takes 
less time by reducing the pressure down gradually to an agreed value and then stopping rather 











Image 3: Flow driver CPAP  Source; J Petty 
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Bi-phasic positive airway pressure (BIPAP) is where two pressure levels are set, a background 
continuous measurement and a higher one which is delivered at intervals either triggered by 
the neonate or set as a mandatory ‘rate’. Infant flow SIPAP © provides bi-level nasal CPAP for 
the spontaneously breathing neonate through the delivery of ‘pulses’ or ‘sighs’ (brief periods of 
increased pressure) above a baseline CPAP pressure (See image 4). These may be timed, or 
‘triggered’ by neonates own inspiratory efforts. (Bhandari, 2010). Literature often refers to the 
setting of these positive pressure ‘sighs’ as nasal intermittent positive pressure ventilation 
(NIPPV; Sweet, 2008; Owen et al, 2008), not to be confused with intermittent positive pressure 
ventilation or IPPV via full intubation as will be covered shortly. A study by Khalaf et al (2001) 
found that NIPPV is more effective that NCPAP in weaning neonates with respiratory distress 
syndrome. A meta-analysis of three studies comparing NIPPV and CPAP after neonates were 
extubated found a reduction in re-intubation rates in the former group (Davies et al, 2001)and 
more recently Lista et al (2010) report, following a randomized controlled trial comparing single 
and bi-level CPAP, found the latter group was associated with improved respiratory outcomes 
allowing earlier discharge. However, Meneses et al (2011) found that early NIPPV did not 
decrease the need for mechanical ventilation compared with NCPAP, overall, in the first 72 
hours of life.  Owen et al (2011) also found no differences between the two in relation to the 






Image 4: Bi-phasic screen showing 2 levels of support 
Source: 
 
Glossary of modes  
CPAP–CPAP is a mode itself on all ventilators as well as support strategy in it’s own right known 
as nCPAP (nasal CPAP). On the Flow driver ©, it can be given with or without ‘apnoea’. If CPAP 
with apnoea is required, then an abdominal transducer is necessary in order to monitor any 
apnoeic episode and raise the alarm according to the apnoea time interval which is set by the 
user. On the older Flow driver module that just delivers one level of CPAP, generally a flow is 
set to 8 litres / minute to aim for a pressure of 5-6 cm / H20 (again subject to assessment of the 
individual baby). The humidifier should be set to deliver gases at 37 degrees Celcius to the 
baby’s airway. 
BIPAP- BIPAP has the following mode options namely: 
• Biphasic timed; The machine delivers a set baseline pressure using the ‘high pressure’ 
flow metre (set to 8 L/minute on average). The extra pressure supported ‘sighs’ are 
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delivered according to a set ‘rate’ and Ti. The user will set the additional pressure with 
the ‘low pressure’ flow metre and will set the number per minute and length of each 
extra sigh. 
 
• Trigger Biphasic; As above but the extra pressure sighs are not timed. These are now 
triggered by the neonate initiating a breath.  
 
• BiPhasic + apnoea - as for biphasic times but there is additional apnoea monitoring and 
an alarm will sound if the neonate does not breathe within the apnoea interval, as for 
CPAP and apnoea above. 
 
• Flow – there are 2 flow meters (See Image 4) on the ‘SIPAP’ model. The left one pictured 
is known as ‘low’ pressure where the CPAP pressure is set. The right hand one is ‘high’ 
pressure which is set 2 litres / minute above the low pressure dial. This is what delivers 
the second or additional pressure when bi-phasic mode is required. It is important not 
to set the ‘high pressure’ flow too high. 
 
When delivering ventilator support to neonates, it is important to be aware of the potential 
negative effects of ventilation (Claure and Bancalari, 2007); for example: lung injury from 
barotrauma (pressure) and / or volume leading to chronic lung disease, oxygen toxicity, 
hypotension, and lung hyperinflation and nosocomial respiratory infection. Bedside assessment 
and monitoring is the key to ensuring any negative effect is identified as soon as possible – e.g. 
CXR findings, blood pressure. Bedside care must keep the negative effects in mind such as 
avoiding high oxygen concentrations, supporting the BP and continuous 02 monitoring. 
Current respiratory support strategies must also have these dangers as a central consideration. 
Overall protective lung strategies that include the use of non-invasive ventilation modes should 
be employed as appropriate from the point of birth and beyond. Surfactant and non-invasive 
modes such as CPAP (Davies et al, 2009)and biphasic ventilation has significantly influenced the 
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current ethos behind the support of preterm neonates with respiratory failure (DiBlasi, 2011), 
Recent  European Guidelines for the management of preterm neonates born with RDS 
recommend very early Surfactant followed by extubation to CPAP as a way of potentially 
reducing lung damage (Sweet et al, 2007) and this is an area of current interest  (SUPPORT 
Study Group, 2010).  The use of early delivery room CPAP is also well documented (Finer et al, 
2004; tePas et  AL, 2007). The Newborn life Support Guidelines (UK Resuscitation Council, 2010) 
support the use of positive end pressure in the stabilisation of preterm babies at delivery as 
required. As, Mulder et al (2012) put forward for discussion, the advent and increasing use of 
non-invasive ventilation strategies should lead to a significantly reduced incidence of chronic 
lung disease from prematurity.  
 
Conclusion 
Technological advances have resulted in improvements in ventilation strategies that offer a 
wider range of non-invasive modalities. Knowledge of the terms used in neonatal clinical 
respiratory practice is valuable since this practice comprises a significant proportion of care 
given to sick neonates within the neonatal unit. It is not possible to cover within the scope of 
this paper, the nursing care given to the neonate receiving the above mentioned strategies; this 
will be the subject of a future edition. Those caring for such sick and vulnerable neonates owe it 
to them and their families to have a full understanding of common but often complex practice 
while at the same time work towards minimising any resultant damage and respiratory 
morbidity. This is not only so that care is supported by best evidence based rationale but also so 
that parents can be given information about the strategies their babies receive and outcomes, a 
vital component of true holistic family centered neonatal care.     
 
Note Subsequent Fact Sheets will follow on from the current topic in future editions; namely, 
the nursing care for neonates on non-invasive respiratory support and an overview of invasive 
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